CYRX on Nasdaq
Cryoport, Inc.
We are a leading global provider of integrated, temperature-controlled supply chain solutions for the life sciences, with a strong focus on supporting the rapidly growing cell and gene therapy.2
Price unavailable
Last updated Oct 19, 2026.
Overview
Compare with Phathom Pharmaceuticals, Inc., Syndax Pharmaceuticals Inc or Kamada Ltd., or pick any stock.
- TickerCYRX on Nasdaq2
- IndustryPharmaceutical Preparations2
- HeadquartersCarson City, United States2
- Incorporated inNV3
- Business address112 Westwood Place, Suite 350, Brentwood, Tn 370273
- Filer categoryAccelerated filer3
- Legal formProfit Corporation2
- LEI9845004D8538BT8JF6262
- StatusActive2
- LEI statusIssued and current2
- Registered address112 NORTH CURRY STREET, 89703 Carson City, United States2
- Registered withBusiness Center (Secretary of State), NV199010226192
See how the biggest companies compare on our leaderboards
We are a leading global provider of integrated, temperature-controlled supply chain solutions for the life sciences, with a strong focus on supporting the rapidly growing cell and gene therapy (“CGT”) market. Our solutions are purpose-built to support a broad range of global life sciences markets, including biopharmaceutical and pharmaceutical companies, the animal health markets, reproductive medicine, academic institutions, research, and government agencies. Our solutions help our customers ensure the safe, compliant storage, handling, and delivery of high value, temperature sensitive biological materials, including cell and gene therapies and immunotherapies.4 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
47.1%Gross margin5
-20.9%Operating margin5
44.4%Net margin5
12.4%Revenue growth, 20255
15.6%Return on equity5
-$25.0MFree cash flow5
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Products and services
Product brought in 45% of the revenue Cryoport, Inc. broke down this way in fiscal 2025.
Products and services by year
| Products and services | 2023 | 2024 | 2025 |
|---|---|---|---|
| Product | $89.2M | $74.7M | $79.7M |
| BioLogistics Solutions | $65.9M | $67.0M | $78.1M |
| Bio Storage/Bio Services | $13.6M | $15.0M | $18.4M |
Business segments
Life Sciences Services brought in 57% of the revenue Cryoport, Inc. broke down this way in fiscal 2025.
Business segments by year
| Business segments | 2023 | 2024 | 2025 |
|---|---|---|---|
| Life Sciences Services | $81.2M | $85.3M | $101.0M |
| Life Sciences Products | $87.5M | $71.4M | $75.1M |
Regions
Americas brought in 75% of the revenue Cryoport, Inc. broke down this way in fiscal 2025.
Regions by year
| Regions | 2023 | 2024 | 2025 |
|---|---|---|---|
| Americas | $117.9M | $113.5M | $131.3M |
| EMEA | $27.6M | $27.0M | $25.1M |
| Asia Pacific | $23.1M | $16.2M | $19.8M |
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Cost of revenue32¢$93.1M
- Research and development6¢$17.0M
- Selling, general and admin35¢$102.8M
- Income tax1¢$1.8M
- Profit27¢$78.3M
Out of $176.2M in revenue.5
Financial statements
Every line of the income statement as filed: the last 3 fiscal years, latest first.5
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Total revenue | $176.2M | $156.8M | $168.7M |
| Total cost of revenue | $93.1M | $87.1M | $93.3M |
| Gross margin | $83.1M | $69.7M | $75.3M |
| Selling, general and administrative | $102.8M | $109.8M | $108.3M |
| Engineering and development | $17.0M | $17.7M | $18.0M |
| Impairment loss | $63.8M | $49.6M | |
| Total operating costs and expenses | $119.9M | $191.3M | $175.9M |
| Loss from operations | -$36.8M | -$121.7M | -$100.5M |
| Investment income | $9.8M | $9.9M | $10.6M |
| Interest expense, net | -$2.4M | -$4.0M | -$5.6M |
| Gain on extinguishment of debt, net | $18.5M | $5.7M | |
| Other income (expense), net | -$2.8M | -$7.1M | $5.6M |
| Total other income, net | $4.6M | $17.3M | $16.3M |
| Loss from continuing operations before provision for income taxes | -$32.2M | -$104.3M | -$84.2M |
| Provision for income taxes | -$1.8M | -$359.0K | -$345.0K |
| Loss from continuing operations | -$34.0M | -$104.7M | -$84.6M |
| Income (loss) from discontinued operations, net | $112.3M | -$10.0M | -$15.0M |
| Net income (loss) | $78.3M | -$114.8M | -$99.6M |
| Paid-in-kind dividend on Series C convertible preferred stock | -$8.0M | -$8.0M | -$8.0M |
| Net income (loss) attributable to common stockholders | $70.3M | -$122.8M | -$107.6M |
| Net loss per share from continuing operations - basic (in dollars per share) | -$1 | -$2 | -$2 |
| Net income (loss) per share from discontinued operations - basic (in dollars per share) | $2 | -$0 | -$0 |
| Net income (loss) per share - basic (in dollars per share) | $1.40 | -$2.49 | -$2.21 |
| Weighted average common shares issued and outstanding - basic (in shares) | 50.1M shares | 49.3M shares | 48.7M shares |
| Net loss per share from continuing operations - diluted (in dollars per share) | -$1 | -$2 | -$2 |
| Net income (loss) per share from discontinued operations - diluted (in dollars per share) | $2 | -$0 | -$0 |
| Net income (loss) per share - diluted (in dollars per share) | $1.40 | -$2.49 | -$2.21 |
| Weighted average common shares issued and outstanding - diluted (in shares) | 50.1M shares | 49.3M shares | 48.7M shares |
No quarter-by-quarter statement was filed.
Every line of the balance sheet as filed: the last 4 fiscal years (annual) or 4 quarters (quarterly), latest first.5
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Cash and cash equivalents | $250.5M | $34.1M | $35.2M | $29.2M |
| Short-term investments | $160.7M | $216.5M | ||
| Accounts receivable, net | $33.4M | $25.3M | ||
| Inventories | $23.2M | $21.5M | ||
| Prepaid expenses and other current assets | $8.4M | $7.9M | ||
| Current assets held for sale | $36.3M | |||
| Total current assets | $476.2M | $341.6M | ||
| Property and equipment, net | $85.4M | $80.0M | ||
| Operating lease right-of-use assets | $39.7M | $39.9M | ||
| Intangible assets, net | $138.1M | $147.9M | ||
| Goodwill | $22.4M | $20.6M | $76.4M | |
| Deposits | $2.1M | $2.0M | ||
| Deferred tax assets | $1.1M | $842.0K | ||
| Long-term assets held for sale | $70.7M | |||
| Total assets | $765.0M | $703.5M | ||
| Accounts payable and other accrued expenses | $15.3M | $15.9M | ||
| Accrued compensation and related expenses | $13.0M | $11.2M | ||
| Deferred revenue | $943.0K | $1.1M | ||
| Current portion of operating lease liabilities | $4.1M | $3.4M | ||
| Current portion of finance lease liabilities | $422.0K | $315.0K | ||
| Current portion of convertible senior notes, net of discount of $1.1 million and $0.1 million, respectively | $185.1M | $14.3M | ||
| Current portion of notes payable | $163.0K | $143.0K | ||
| Current portion of contingent consideration | $2.8M | |||
| Current liabilities held for sale | $15.4M | |||
| Total current liabilities | $219.0M | $64.6M | ||
| Convertible senior notes, net of current portion and discount of $0 and $2.3 million, respectively | $183.9M | |||
| Notes payable, net of current portion | $1.1M | $1.1M | ||
| Operating lease liabilities, net of current portion | $39.1M | $38.6M | ||
| Finance lease liabilities, net of current portion | $741.0K | $800.0K | ||
| Deferred tax liabilities | $1.4M | $804.0K | ||
| Other long-term liabilities | $444.0K | $295.0K | ||
| Contingent consideration, net of current portion | $629.0K | $3.8M | ||
| Long-term liabilities held for sale | $7.8M | |||
| Total liabilities | $262.4M | $301.6M | ||
| Common stock, $0.001 par value; 100,000,000 shares authorized; 49,850,793 and 49,908,254 issued and outstanding at December 31, 2025 and December 31, 2024, respectively | $50.0K | $50.0K | ||
| Additional paid-in capital | $1.2B | $1.1B | ||
| Accumulated deficit | -$688.9M | -$757.2M | ||
| Accumulated other comprehensive loss | -$3.5M | -$20.9M | ||
| Total stockholders' equity | $502.6M | $401.9M | $489.0M | $555.8M |
| Total liabilities and stockholders' equity | $765.0M | $703.5M | ||
| Convertible senior notes current, discount | $1.1M | $100.0K | ||
| Convertible senior notes noncurrent, discount | $0 | $2.3M | ||
| Preferred stock, par value per share (in dollars per share) | $0.00 | $0.00 | ||
| Preferred stock, shares authorized | 2.5M shares | 2.5M shares | ||
| Common stock, par value per share (in dollars per share) | $0.00 | $0.00 | ||
| Common stock, shares authorized | 100.0M shares | 100.0M shares | ||
| Common stock, shares issued | 49.9M shares | 49.9M shares | ||
| Common stock, shares outstanding | 49.9M shares | 49.9M shares |
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Cash and cash equivalents | $250.5M | $34.1M | $35.2M | $29.2M |
| Short-term investments | $160.7M | $216.5M | ||
| Accounts receivable, net | $33.4M | $25.3M | ||
| Inventories | $23.2M | $21.5M | ||
| Prepaid expenses and other current assets | $8.4M | $7.9M | ||
| Current assets held for sale | $36.3M | |||
| Total current assets | $476.2M | $341.6M | ||
| Property and equipment, net | $85.4M | $80.0M | ||
| Operating lease right-of-use assets | $39.7M | $39.9M | ||
| Intangible assets, net | $138.1M | $147.9M | ||
| Goodwill | $22.4M | $20.6M | $76.4M | |
| Deposits | $2.1M | $2.0M | ||
| Deferred tax assets | $1.1M | $842.0K | ||
| Long-term assets held for sale | $70.7M | |||
| Total assets | $765.0M | $703.5M | ||
| Accounts payable and other accrued expenses | $15.3M | $15.9M | ||
| Accrued compensation and related expenses | $13.0M | $11.2M | ||
| Deferred revenue | $943.0K | $1.1M | ||
| Current portion of operating lease liabilities | $4.1M | $3.4M | ||
| Current portion of finance lease liabilities | $422.0K | $315.0K | ||
| Current portion of convertible senior notes, net of discount of $1.1 million and $0.1 million, respectively | $185.1M | $14.3M | ||
| Current portion of notes payable | $163.0K | $143.0K | ||
| Current portion of contingent consideration | $2.8M | |||
| Current liabilities held for sale | $15.4M | |||
| Total current liabilities | $219.0M | $64.6M | ||
| Convertible senior notes, net of current portion and discount of $0 and $2.3 million, respectively | $183.9M | |||
| Notes payable, net of current portion | $1.1M | $1.1M | ||
| Operating lease liabilities, net of current portion | $39.1M | $38.6M | ||
| Finance lease liabilities, net of current portion | $741.0K | $800.0K | ||
| Deferred tax liabilities | $1.4M | $804.0K | ||
| Other long-term liabilities | $444.0K | $295.0K | ||
| Contingent consideration, net of current portion | $629.0K | $3.8M | ||
| Long-term liabilities held for sale | $7.8M | |||
| Total liabilities | $262.4M | $301.6M | ||
| Common stock, $0.001 par value; 100,000,000 shares authorized; 49,850,793 and 49,908,254 issued and outstanding at December 31, 2025 and December 31, 2024, respectively | $50.0K | $50.0K | ||
| Additional paid-in capital | $1.2B | $1.1B | ||
| Accumulated deficit | -$688.9M | -$757.2M | ||
| Accumulated other comprehensive loss | -$3.5M | -$20.9M | ||
| Total stockholders' equity | $502.6M | $401.9M | $489.0M | $555.8M |
| Total liabilities and stockholders' equity | $765.0M | $703.5M | ||
| Convertible senior notes current, discount | $1.1M | $100.0K | ||
| Convertible senior notes noncurrent, discount | $0 | $2.3M | ||
| Preferred stock, par value per share (in dollars per share) | $0.00 | $0.00 | ||
| Preferred stock, shares authorized | 2.5M shares | 2.5M shares | ||
| Common stock, par value per share (in dollars per share) | $0.00 | $0.00 | ||
| Common stock, shares authorized | 100.0M shares | 100.0M shares | ||
| Common stock, shares issued | 49.9M shares | 49.9M shares | ||
| Common stock, shares outstanding | 49.9M shares | 49.9M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 3 fiscal years, latest first.5
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Net income (loss) | $78.3M | -$114.8M | -$99.6M |
| Impairment loss | $63.8M | $49.6M | |
| Depreciation and amortization | $27.7M | $30.8M | $27.5M |
| Amortization of debt discount | $1.2M | $1.9M | $2.5M |
| Non-cash operating lease expense | $6.6M | $5.8M | $5.1M |
| Unrealized (gain) loss on investments in equity securities | -$1.5M | $899.0K | -$1.3M |
| Realized loss on investments in equity securities | $48.0K | ||
| Realized loss on available-for-sale investments | $2.2M | $4.1M | $67.0K |
| Gain on extinguishment of debt | -$18.5M | -$5.7M | |
| Gain on divested business | -$117.0M | ||
| Stock-based compensation expense | $11.0M | $19.7M | $22.8M |
| Loss on disposal of property and equipment | $1.0M | $384.0K | $954.0K |
| Gain on insurance settlement | -$2.6M | ||
| Change in credit losses | $304.0K | -$242.0K | $822.0K |
| Excess and obsolete inventory | $393.0K | $234.0K | |
| Insurance proceeds for operations | $1.2M | ||
| Change in contingent consideration | -$5.2M | -$1.8M | -$890.0K |
| Accounts receivable | -$6.5M | -$4.1M | $3.7M |
| Inventories | -$2.2M | $3.3M | $1.5M |
| Prepaid expenses and other current assets | $1.4M | -$2.1M | -$103.0K |
| Deposits | -$189.0K | -$1.4M | -$663.0K |
| Operating lease liabilities | -$5.0M | -$5.3M | -$4.6M |
| Accounts payable and other accrued expenses | -$3.5M | -$76.0K | -$2.8M |
| Accrued compensation and related expenses | $1.9M | $1.9M | $2.9M |
| Deferred revenue | -$216.0K | -$179.0K | $842.0K |
| Net deferred tax liability | $661.0K | -$377.0K | -$2.0M |
| Net cash used in operating activities | -$8.6M | -$16.3M | -$757.0K |
| Purchases of property and equipment | -$16.4M | -$17.3M | -$38.8M |
| Insurance proceeds for loss of fixed assets | $976.0K | ||
| Software development costs | -$1.8M | -$2.9M | -$5.2M |
| Purchases of short-term investments | -$50.7M | -$42.7M | |
| Proceeds from divested business | $210.2M | ||
| Cash paid for acquisitions | -$313.0K | -$7.3M | |
| Sales/maturities of short-term investments | $59.6M | $249.1M | $130.0M |
| Patent and trademark costs | -$1.2M | -$1.1M | -$871.0K |
| Net cash provided by investing activities | $250.3M | $176.8M | $36.0M |
| Proceeds from exercise of stock options | $4.0M | $2.8M | $1.5M |
| Repurchase of common stock | -$10.0M | ||
| Repayment of notes payable | -$161.0K | -$141.0K | -$71.0K |
| Repayment of finance lease liabilities | -$530.0K | -$408.0K | -$202.0K |
| Net cash used in financing activities | -$21.1M | -$161.5M | -$23.8M |
| Effect of exchange rates on cash and cash equivalents | -$15.5M | -$18.0K | -$1.7M |
| Net change in cash and cash equivalents | $205.2M | -$1.1M | $9.8M |
| Cash paid for interest | $1.6M | $2.7M | $3.4M |
| Cash paid for income taxes | $2.2M | $1.4M | $1.5M |
| Operating lease right-of-use assets and operating lease liabilities | $6.6M | $21.0M | $11.1M |
| Net unrealized gain on available-for-sale debt securities | $1.5M | $2.9M | $6.7M |
| Reclassification of realized gain (loss) on available-for-sale debt securities to earnings | $3.0M | -$6.6M | -$3.0M |
| Paid-in-kind preferred stock dividend, including beneficial conversion feature | $8.0M | $8.0M | $8.0M |
| Fixed assets included in accounts payable and accrued liabilities | $218.0K | $103.0K | $442.0K |
| Intangible assets included in property and equipment | $252.0K | $8.7M | |
| Contingent consideration reclassed to accounts payable and accrued liabilities | $881.0K | ||
| Purchase of equipment through finance lease obligation | $388.0K | $936.0K | $1.1M |
No quarter-by-quarter statement was filed.
Leadership
Who has led Cryoport, Inc., and when. Pick a name to see everywhere that person has worked.
Chief financial officer
2010201520202025
- Chief executive officerJerrell Shelton May 8, 2013 to now13
- Chief executive officerLarry G. Stambaugh Aug 3, 2009 to Oct 5, 201014
- Chief executive officerPeter Berry Apr 24, 2008 to Dec 16, 200815
- ChairLarry G. Stambaugh Aug 3, 2009 to Feb 16, 201014
- PresidentJerrell Shelton Apr 3, 2019 to now16
- PresidentLarry G. Stambaugh Aug 3, 2009 to Oct 5, 201014
- Chief financial officerRobert Stefanovich Jul 7, 2011 to now17
- Chief financial officerCatherine M. Doll Aug 28, 2009 to Feb 16, 201018
Board members and other officers (21)
- Chief Digital and Tech OfficerEdward J. Zecchini Mar 19, 2024 to now19
- OfficerJerrell Shelton Sep 5, 2023 to Sep 5, 202320
- Chief Scientific OfficerMark W. Sawicki Mar 4, 2021 to now21
- Chief Commercial OfficerSteven L. Leatherman Apr 5, 2012 to Jul 2, 201322
- Chief Commercial OfficerMark Englehart Jun 10, 2011 to Jun 10, 201123
- OfficerMichael Bartholomew Sep 29, 2010 to Oct 18, 201024
- SecretaryCarlton M. Johnson Jul 9, 2009 to Oct 5, 201025
- Board memberLinda Baddour Mar 17, 2021 to now26
- Board memberRam M. Jagannath Oct 13, 2020 to Oct 13, 202027
- Board memberDaniel M. Hancock Jan 8, 2019 to now28
- Board memberRobert J. Hariri Nov 24, 2015 to now29
- Board memberRamkumar Mandalam Jun 20, 2014 to now30
- Board memberRichard G. Rathmann Apr 1, 2013 to Jan 4, 201631
- Board memberEdward J. Zecchini Oct 7, 2013 to May 16, 202332
- Board memberJerrell Shelton Oct 30, 2012 to now33
- Board memberKaren M. Muller Jun 13, 2011 to Dec 14, 201234
- Board memberJohn H. Bonde Feb 17, 2010 to Oct 5, 201035
- Board memberLarry G. Stambaugh Sep 17, 2010 to Oct 5, 201036
- Board memberCarlton M. Johnson Jul 9, 2009 to Oct 5, 201025
- Board memberAdam Michelin Aug 25, 2009 to Dec 14, 201237
- Board memberPeter Berry Apr 24, 2008 to May 11, 200915
Former names
- CRYOPORT SYSTEMS INCOct 20, 2005 to Oct 20, 20053
Timeline
Filings
285 filings to the SEC since October 2021: 5 annual reports, 15 quarterly reports, 40 major events, 122 insider forms, 41 large holders, 62 other. The latest 20:
- Aug 14, 2026SCHEDULE 13G/A EDGAR
- Aug 13, 2026SCHEDULE 13G/A EDGAR
- Aug 11, 2026144 EDGAR
- Aug 11, 20264 OWNERSHIP DOCUMENT EDGAR
- Aug 6, 202610-Q EDGAR
- Aug 6, 20268-K EDGAR
- Jul 29, 2026SCHEDULE 13G/A EDGAR
- Jun 22, 202615-12G EDGAR
- Jun 22, 2026S-8 EDGAR
- Jun 12, 20264 OWNERSHIP DOCUMENT EDGAR
- Jun 11, 2026144 EDGAR
- Jun 10, 2026144 EDGAR
- Jun 9, 20268-K EDGAR
- Jun 9, 20264 OWNERSHIP DOCUMENT EDGAR
- Jun 8, 2026144 EDGAR
- Jun 8, 20264 OWNERSHIP DOCUMENT EDGAR
- Jun 8, 20264 OWNERSHIP DOCUMENT EDGAR
- Jun 8, 20264 OWNERSHIP DOCUMENT EDGAR
- Jun 8, 20264 OWNERSHIP DOCUMENT EDGAR
- Jun 3, 2026144 EDGAR
The 285 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Insider trades
89 open-market trades by officers, directors and large owners since October 2021: 0 buys and 89 sales. Grants, option exercises and gifts are left out.
| Date | Who | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 11, 2026 | SHELTON JERRELLPresident, CEO | Sale | 28,800 | $14.91 | $429.4K | Form 4 |
| Jun 11, 2026 | ZECCHINI EDWARD JChief Digital and Tech Officer | Sale | 33,600 | $14.47 | $486.2K | Form 4 |
| Jun 10, 2026 | ZECCHINI EDWARD JChief Digital and Tech Officer | Sale | 1,400 | $15.23 | $21.3K | Form 4 |
| Jun 8, 2026 | Mandalam RamkumarDirector | Sale | 23,214 | $15.44 | $358.4K | Form 4 |
| Jun 4, 2026 | STEFANOVICH ROBERTChief Financial Officer | Sale | 169,427 | $16.27 | $2.8M | Form 4 |
| Mar 23, 2026 | STEFANOVICH ROBERTChief Financial Officer | Sale | 1,094 | $8.18 | $8.9K | Form 4 |
| Mar 23, 2026 | SHELTON JERRELLPresident, CEO | Sale | 2,894 | $8.18 | $23.7K | Form 4 |
| Mar 23, 2026 | Sawicki Mark WChief Scientific Officer | Sale | 1,341 | $8.18 | $11.0K | Form 4 |
| Mar 16, 2026 | ZECCHINI EDWARD JChief Digital and Tech Officer | Sale | 2,014 | $8.00 | $16.1K | Form 4 |
| Mar 16, 2026 | SHELTON JERRELLPresident, CEO | Sale | 7,918 | $8.00 | $63.3K | Form 4 |
| Mar 16, 2026 | Sawicki Mark WChief Scientific Officer | Sale | 3,235 | $8.00 | $25.9K | Form 4 |
| Mar 16, 2026 | STEFANOVICH ROBERTChief Financial Officer | Sale | 2,743 | $8.00 | $21.9K | Form 4 |
| Mar 12, 2026 | STEFANOVICH ROBERTChief Financial Officer | Sale | 38,700 | $7.76 | $300.3K | Form 4 |
| Dec 10, 2025 | Mandalam RamkumarDirector | Sale | 11,570 | $9.99 | $115.6K | Form 4 |
| Sep 11, 2025 | Hariri Robert JDirector | Sale | 25,000 | $9.71 | $242.8K | Form 4 |
| Aug 22, 2025 | Hariri Robert JDirector | Sale | 5,000 | $8.60 | $43.0K | Form 4 |
| Aug 19, 2025 | STEFANOVICH ROBERTChief Financial Officer | Sale | 9,300 | $8.67 | $80.6K | Form 4 |
| Jul 22, 2025 | Mandalam RamkumarDirector | Sale | 40,728 | $7.24 | $294.9K | Form 4 |
| Jun 24, 2025 | SHELTON JERRELLPresident, CEO | Sale | 16,344 | $7.06 | $115.4K | Form 4 |
| Jun 24, 2025 | Mandalam RamkumarDirector | Sale | 13,321 | $7.02 | $93.5K | Form 4 |
All 89 trades can be filtered by person here when JavaScript is on.
From Forms 4 filed with the SEC.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- CADIAN CAPITAL MANAGEMENT, LPSCHEDULE 13G/A, 4 filings Feb 14, 2024 to Aug 14, 202638
- Morgan StanleySCHEDULE 13G/A, 2 filings Feb 8, 2024 to Aug 13, 202639
- INTEGRATED CORE STRATEGIES (US) LLCSCHEDULE 13G/A, 6 filings Sep 3, 2024 to Jul 29, 202640
- VANGUARD GROUP INCSCHEDULE 13G/A, 6 filings Feb 9, 2022 to Mar 26, 202641
- BROWN CAPITAL MANAGEMENT LLCSCHEDULE 13G/A, 10 filings Mar 10, 2022 to Feb 17, 202642
- ALGER ASSOCIATES INCSCHEDULE 13G/A, 7 filings Jan 10, 2022 to Aug 14, 202543
- InvescoSC 13G/A, 2 filings Feb 9, 2022 to Feb 8, 202344
- Blackstone Holdings III L.P.SC 13D/A, 1 filing Nov 18, 202145
Held by these funds
The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 100. Change is in shares since the quarter before.
| Fund | Shares | Value | Share of the fund | Change |
|---|---|---|---|---|
| BlackRock, Inc. | 4,218,434 | $66.2M | 0.0% | +237,536 |
| Cadian Capital Management, LP | 2,920,681 | $45.9M | 3.5% | −1,855,662 |
| First Eagle Investment Management, LLC | 2,542,848 | $39.9M | 0.0% | +1,797,999 |
| Assenagon Asset Management S.A. | 2,304,622 | $36.2M | 0.0% | +808,939 |
| Morgan Stanley | 2,276,741 | $35.7M | 0.0% | −2,299,989 |
| Vanguard Capital Management LLC | 2,151,943 | $33.8M | 0.0% | +33,087 |
| Millennium Management LLC | 1,724,726 | $27.1M | 0.0% | −1,245,738 |
| Fred Alger Management, LLC | 1,545,293 | $24.3M | 0.1% | −154,086 |
| Geode Capital Management, LLC | 1,312,370 | $20.6M | 0.0% | +64,235 |
| Mak Capital One LLC | 1,277,359 | $20.1M | 2.8% | −145,906 |
| State Street Corp | 1,046,875 | $16.4M | 0.0% | +62,997 |
| Dimensional Fund Advisors LP | 1,000,095 | $15.7M | 0.0% | +76,388 |
| Nuveen, LLC | 922,935 | $14.5M | 0.0% | +822,319 |
| UBS Group AG | 868,266 | $13.6M | 0.0% | −64,516 |
| Silvercrest Asset Management Group LLC | 858,684 | $13.5M | 0.1% | −42,326 |
| Meros Investment Management, LP | 743,312 | $11.7M | 3.7% | +134,239 |
| Needham Investment Management LLC | 717,000 | $11.3M | 0.3% | +357,000 |
| Brown Capital Management LLC | 670,057 | $10.5M | 2.1% | −110,507 |
| Deutsche Bank Ag\ | 654,889 | $10.3M | 0.0% | −345,787 |
| Intrinsic Edge Capital Management LLC | 630,000 | $9.9M | 1.2% | No change |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 575,364 | $9.0M | 0.0% | −202,997 |
| Vanguard Portfolio Management LLC | 562,869 | $8.8M | 0.0% | +49,235 |
| Wellington Management Group Llp | 534,930 | $8.4M | 0.0% | New |
| Mirova | 518,000 | $8.1M | 0.3% | −640,277 |
| Parkman Healthcare Partners LLC | 508,324 | $8.0M | 0.8% | New |
13F reports cover disclosed long positions in U.S. stocks only.
Members of Congress who traded it
18 trades disclosed by members of Congress. “Vs S&P since” is the stock’s change since the trade minus the S&P 500’s.
| Date | Member | Trade | Amount | Vs S&P since | Filing |
|---|---|---|---|---|---|
| Sep 15, 2023 | Josh GottheimerDemocratic, House | Sale | $1,001 - $15,000 | +57.8% | Report |
| Feb 28, 2022 | Donald S. Beyer, Jr.Democratic, House | Sale | $1,001 - $15,000 | +127.7% | Report |
| Jan 31, 2022 | Donald S. Beyer, Jr.Democratic, House | Sale | $1,001 - $15,000 | +131.2% | Report |
| Jan 14, 2022 | Donald S. Beyer, Jr.Democratic, House | Sale | $1,001 - $15,000 | +129.1% | Report |
| Jan 13, 2022 | Donald S. Beyer, Jr.Democratic, House | Sale | $1,001 - $15,000 | +129.4% | Report |
| Sep 21, 2021 | Donald S. Beyer, Jr.Democratic, House | Sale | $1,001 - $15,000 | +152.6% | Report |
| Nov 24, 2020 | Gilbert Ray Cisneros, Jr.Democratic, House | Partial sale | $1,001 - $15,000 | +175.7% | Report |
| Nov 17, 2020 | Donald S. Beyer, Jr.Democratic, House | Buy | $1,001 - $15,000 | −177.7% | Report |
| Nov 13, 2020 | Josh GottheimerDemocratic, House | Partial sale | $1,001 - $15,000 | +187.0% | Report |
| Nov 2, 2020 | Donald S. Beyer, Jr.Democratic, House | Buy | $1,001 - $15,000 | −192.8% | Report |
| Jul 14, 2020 | Donald S. Beyer, Jr.Democratic, House | Sale | $1,001 - $15,000 | +191.4% | Report |
| May 7, 2020 | Donald S. Beyer, Jr.Democratic, House | Sale | $1,001 - $15,000 | +186.7% | Report |
| Feb 18, 2020 | Donald S. Beyer, Jr.Democratic, House | Buy | $1,001 - $15,000 | −135.6% | Report |
| Feb 6, 2020 | Gilbert Ray Cisneros, Jr.Democratic, House | Buy | $1,001 - $15,000 | −141.6% | Report |
| Jan 17, 2020 | Gilbert Ray Cisneros, Jr.Democratic, House | Buy | $1,001 - $15,000 | −145.1% | Report |
| Jan 14, 2020 | Josh GottheimerDemocratic, House | Buy | $1,001 - $15,000 | −148.1% | Report |
| Jan 13, 2020 | Donald S. Beyer, Jr.Democratic, House | Buy | $1,001 - $15,000 | −143.4% | Report |
| Dec 23, 2019 | Donald S. Beyer, Jr.Democratic, House | Buy | $1,001 - $15,000 | −137.3% | Report |
Members report amounts as ranges, not exact figures. Returns are price-only (no dividends).
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARCryoport, Inc. filings on SEC EDGAR
- 2
- 3SEC EDGARCryoport, Inc. filings on SEC EDGAR
- 4
- 5SEC EDGARCryoport, Inc. 10-K for fiscal 2025
- 6SEC EDGARCryoport, Inc. 10-K for fiscal 2019
- 7SEC EDGARCryoport, Inc. 10-K for fiscal 2020
- 8SEC EDGARCryoport, Inc. 10-K for fiscal 2021
- 9SEC EDGARCryoport, Inc. 10-K for fiscal 2022
- 10SEC EDGARCryoport, Inc. 10-Q for fiscal 2026
- 11SEC EDGARCryoport, Inc. 10-Q for fiscal 2026
- 12SEC EDGARCryoport, Inc. 10-K for fiscal 2019
- 13
- 14
- 15SEC EDGARPeter Berry, Chief executive officer
- 16SEC EDGARJerrell Shelton, President
- 17
- 18
- 19
- 20SEC EDGARJerrell Shelton, Officer
- 21
- 22
- 23
- 24SEC EDGARMichael Bartholomew, Officer
- 25SEC EDGARCarlton M. Johnson, Secretary
- 26SEC EDGARLinda Baddour, Board member
- 27SEC EDGARRam M. Jagannath, Board member
- 28SEC EDGARDaniel M. Hancock, Board member
- 29SEC EDGARRobert J. Hariri, Board member
- 30SEC EDGARRamkumar Mandalam, Board member
- 31SEC EDGARRichard G. Rathmann, Board member
- 32SEC EDGAREdward J. Zecchini, Board member
- 33SEC EDGARJerrell Shelton, Board member
- 34SEC EDGARKaren M. Muller, Board member
- 35SEC EDGARJohn H. Bonde, Board member
- 36SEC EDGARLarry G. Stambaugh, Board member
- 37SEC EDGARAdam Michelin, Board member
- 38
- 39
- 40
- 41
- 42
- 43
- 44SEC EDGARInvesco SC 13G/A on Cryoport, Inc.
- 45